BioVaxys Technology Corp. (CSE:BIOV)

Canada · Delayed Price · Currency is CAD

0.0700

+0.0100 (16.67%)

May 5, 2026, 3:55 PM EST

BioVaxys Technology Financials Overview

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Operating Income	-4.64	-3.12	-2.4	-3.8	-5.98	-1.01
Net Income	-5.97	-3.95	-7.69	-11.73	-6.46	-1.17
Earnings Per Share	-0.22	-0.20	-0.57	-1.19	-0.78	-0.42
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Cash & Investments	0	0.21	0	0.14	0.59	2.42
Total Debt	0.13	0.07	-	-	-	-
Net Cash (Debt)	-0.13	0.14	0	0.14	0.59	2.42
Net Cash Growth	-	14610.95%	-99.31%	-76.08%	-75.52%	958.21%
Net Cash Per Share	-0.00	0.01	0.00	0.01	0.07	0.86

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Operating Cash Flow	-2.97	-1.86	-1.05	-1.57	-5.29	-1.23
Free Cash Flow	-2.97	-1.86	-1.05	-1.57	-5.29	-1.23
Free Cash Flow Growth	-	-	-	-	-	-

Valuation

Selected indicators aren't available for this stock.